Abexxa Biologics - Ownership and Business Overview

Life ScienceCompany

Abexxa Biologics Ownership

Who owns Abexxa Biologics?

Abexxa Biologics is owned by Boehringer Ingelheim. It was acquired on September 21, 2021.

Abexxa Biologics Business Overview

Where is Abexxa Biologics headquartered?

Abexxa Biologics is headquartered in Arlington, Texas.

What sector is Abexxa Biologics in?

Abexxa Biologics is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 386 acquisitions of life science companies in 2021, including 43 acquisitions by private equity firms, and 343 by strategics.

Abexxa Biologics

Abexxa Biologics, Inc.

500 S. Cooper St.,
Arlington, Texas 76019
United States,
(817) 901-9610
www.abexxa.com

Abexxa Biologics is a biopharmaceutical company taking an approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused on developing novel therapeutics around its newly discovered class of intracellular antigens (atypical HLA-peptide complexes) on cancerous cells. Abexxa Biologics is based in Arlington, Texas.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.